Captrust Financial Advisors Has $262,000 Stock Holdings in Stevanato Group S.p.A. (NYSE:STVN)

Captrust Financial Advisors raised its holdings in Stevanato Group S.p.A. (NYSE:STVN) by 12.7% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 13,100 shares of the company’s stock after acquiring an additional 1,480 shares during the quarter. Captrust Financial Advisors’ holdings in Stevanato Group were worth $262,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Thrivent Financial for Lutherans acquired a new stake in Stevanato Group in the second quarter valued at $30,477,000. Pembroke Management LTD increased its stake in shares of Stevanato Group by 143.7% in the third quarter. Pembroke Management LTD now owns 1,051,140 shares of the company’s stock valued at $21,023,000 after buying an additional 619,747 shares during the period. Tri Locum Partners LP bought a new position in shares of Stevanato Group during the second quarter worth about $10,370,000. Thornburg Investment Management Inc. lifted its stake in shares of Stevanato Group by 279.1% in the second quarter. Thornburg Investment Management Inc. now owns 746,218 shares of the company’s stock worth $13,690,000 after acquiring an additional 549,378 shares during the period. Finally, Conestoga Capital Advisors LLC boosted its holdings in Stevanato Group by 7.3% in the second quarter. Conestoga Capital Advisors LLC now owns 7,275,823 shares of the company’s stock valued at $133,439,000 after acquiring an additional 496,930 shares during the last quarter.

Stevanato Group Stock Up 3.7 %

Stevanato Group stock opened at €23.31 ($24.54) on Friday. The firm’s fifty day moving average is €19.67 and its 200 day moving average is €19.67. The company has a market capitalization of $6.89 billion, a PE ratio of 49.60, a PEG ratio of 9.79 and a beta of 0.59. Stevanato Group S.p.A. has a 12-month low of €16.56 ($17.43) and a 12-month high of €34.73 ($36.56). The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN) last issued its earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). The business had revenue of €277.90 million for the quarter, compared to the consensus estimate of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The company’s revenue was up 2.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.16 EPS. As a group, sell-side analysts predict that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

STVN has been the subject of several analyst reports. Morgan Stanley restated an “equal weight” rating and set a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. Wolfe Research started coverage on shares of Stevanato Group in a report on Friday. They issued an “outperform” rating and a $28.00 target price on the stock. Finally, Bank of America increased their price target on Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a report on Friday. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of €28.60 ($30.11).

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.